In luminal muscle‐invasive bladder cancer (MIBC), lncRNA profiling identified a subset of tumours with more favourable outcomes and enriched FGFR3 signalling, suggesting potential candidates for FGFR3‐targeted therapy.11, 37. The gene discussed is FGFR3; the disease is neoplasm.